Diagnostics News and Research

RSS

Forsyth Institute to provide research and development support for saliva-based COVID-19 tests

As a world leader in oral biology and salivary diagnostics, the Forsyth Institute is working with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative as an advisor and critical resource in the effort to develop and eventually deploy millions of accurate, rapid COVID-19 point-of-care tests used daily in schools, colleges, universities, and for testing underserved populations.

26 Aug 2020

New biosensors detect disease-specific miRNA

University of Queensland researchers have developed biosensors that use nanoengineered porous gold which more effectively detect early signs of disease, potentially improving patient outcomes.

25 Aug 2020

Researchers identify potential drug target for curtailing cancer metastasis

Researchers led by Ludwig Chicago Co-director Ralph Weichselbaum and Ronald Rock of the University of Chicago have identified in preclinical studies a potential drug target for curtailing cancer metastasis.

24 Aug 2020

Wide personality traits and attributes can be predicted from social media information

Principle Investigator HARUNO Masahiko and Dr. MORI Kazuma at the Center for Information and Neural Networks, the National Institute of Information and Communications Technology (NICT, President: TOKUDA Hideyuki, Ph.D.), report the use of machine learning to analyze behavior on Twitter and predict a wide range of personality traits and attributes such as intelligence and extraversion.

24 Aug 2020

New COVID-19 pooling test detects asymptomatic carriers

A new peer-reviewed study published in Science Advances confirms the success of a new COVID-19 pooling test that identifies all positive subjects, including asymptomatic carriers, in a single round of testing.

21 Aug 2020

Harvard's Wyss Institute launches Torus Biosystems to develop, commercialize DNA nanotechnology

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.

21 Aug 2020

VUMC receives $34 million grant for nationwide convalescent plasma study

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of "convalescent plasma" as a treatment for COVID-19.

21 Aug 2020

Artificial intelligence can help detect heart disease based on facial photos

Sending a "selfie" to the doctor could be a cheap and simple way of detecting heart disease, according to the authors of a new study published today (Friday) in the European Heart Journal .

21 Aug 2020

California’s data failures stymie efforts to curb the virus

The failure of California's infectious disease monitoring system for a stretch of at least 20 days in July and August triggered potentially deadly fallout that continues to reverberate across the state.

21 Aug 2020

The Native Antigen Company announces custom contract service to develop influenza A and B antigens

The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the introduction of its custom contract service to rapidly develop antigen panels for influenza A and B viruses.

21 Aug 2020

Avacta expands multi-target collaboration with LG Chem Life Sciences

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce the expansion of its existing multi-target collaboration and development agreement with LG Chem Life Sciences (LG Chem), the life sciences division of the South Korean LG Group, to include new programs incorporating Avacta’s Affimer XT serum half-life extension system.

From Avacta Life Sciences Ltd. 21 Aug 2020

AnteoTech's COVID-19 antigen and Flu A&B test detects SARS-Cov-2, influenza in less than 15 minutes

AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes.

21 Aug 2020

New book series advances the development of pharmaceutical agents for treating neurological, CNS disorders

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.

21 Aug 2020

Exeter experts organize global AI summit to address ongoing healthcare crisis

A global summit which aims to boost effective collaboration between experts working in Artificial Intelligence (AI) is being organised by academics at the University of Exeter.

20 Aug 2020

Study shows why certain genetically predisposed individuals do not develop heart disease

Life can change dramatically when someone learns they are genetically predisposed to a disease, such as a condition called familial hypercholesterolemia, where a mutated gene can lead to elevated cholesterol and increased risk for a premature heart attack.

20 Aug 2020